Antiretroviral Medication Diversion Among HIV-Positive Substance Abusers in South Florida

Dados Bibliográficos

ID11022711
AutoresHilary L Surratt (0000-0003-4027-7840, At the time of the study, Hilary L. Surratt, Steven P. Kurtz, Catherine O’Grady, and Maria A. Levi-Minzi were with the Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL, and the Center for Drug and Alcohol Studies, University of Delaware, Newark. Theodore J. Cicero was with the Department of Psychiatry, Washington University School of Medicine, St Louis, MO.), Steven P Kurtz (0000-0002-4243-8129, At the time of the study, Hilary L. Surratt, Steven P. Kurtz, Catherine O’Grady, and Maria A. Levi-Minzi were with the Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL, and the Center for Drug and Alcohol Studies, University of Delaware, Newark. Theodore J. Cicero was with the Department of Psychiatry, Washington University School of Medicine, St Louis, MO.), Theodore J Cicero (0000-0002-4716-3398, At the time of the study, Hilary L. Surratt, Steven P. Kurtz, Catherine O’Grady, and Maria A. Levi-Minzi were with the Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL, and the Center for Drug and Alcohol Studies, University of Delaware, Newark. Theodore J. Cicero was with the Department of Psychiatry, Washington University School of Medicine, St Louis, MO.), Catherine O’Grady (At the time of the study, Hilary L. Surratt, Steven P. Kurtz, Catherine O’Grady, and Maria A. Levi-Minzi were with the Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL, and the Center for Drug and Alcohol Studies, University of Delaware, Newark. Theodore J. Cicero was with the Department of Psychiatry, Washington University School of Medicine, St Louis, MO.), Maria A Levi-Minzi (At the time of the study, Hilary L. Surratt, Steven P. Kurtz, Catherine O’Grady, and Maria A. Levi-Minzi were with the Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Fort Lauderdale, FL, and the Center for Drug and Alcohol Studies, University of Delaware, Newark. Theodore J. Cicero was with the Department of Psychiatry, Washington University School of Medicine, St Louis, MO.), Maria A Levi‐Minzi (Nova Southeastern University)
Ano2013
Volume103
Fascículo6
Páginas1026-1028
Data de publicação2013-06-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoAmerican Journal of Public Health (JOURNAL)
Identificadores do periódicoISSN: 0090-0036 • E-ISSN: 1541-0048
EditoraAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2012.301092
PMID23597362
PMCIDPMC3670661
OpenAlexW2138531039
IdiomaEN
Citações recebidas19
Referências citadas12

The high cost of life-saving antiretroviral (ARV) therapy for HIV represents an expense that impedes accessibility and affordability by patients. This price structure also appears to motivate the diversion of ARVs and the targeting of HIV-positive patients by pill brokers in the illicit market. Our field research with indigent, HIV-positive substance abusers links ARV diversion to high levels of competing needs, including psychiatric disorders, HIV stigma, and homelessness. Interventions to reduce diversion must address the needs of highly vulnerable patients

Antiretroviral therapy · Environmental health · Family medicine · Human immunodeficiency virus (HIV) · Pill · Psychiatry · Psychological intervention · Stigma (botany) · Substance abuse · Substance use · Viral load · HIV-related health complications and treatments · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Nursing